Sunday House Call, #777, February 14, 2021
This week the NEJM published a study concluding “In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.”
A follow up editorial provides some perspective.
Your calls about:
- Can mouthwash and nasal rinses prevent Covid-19 infections?
- What are the clinical indications for intubation?
- The appearance of variants in Canada and around the world. Do they share similar mutations?
- Blood pressure checks.
A discussion with the co-author of Canada’s weight management guidelines Dr. Sean Wharton
Dr. David Macklin discusses what we know about the influences on our appetite and weight.
Not "game-changing" but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity. Play Now | Play in Popup | Download